Core Viewpoint - The company, United Imaging Healthcare, has officially entered the ultrasound market with the launch of its uSONIQUE series products, leveraging AI technology to cover a wide range of applications in the medical imaging sector [1][3]. Group 1: Product Launch and Market Position - United Imaging Healthcare has released the uSONIQUE series, which includes high-end to economical ultrasound products, supporting various medical applications such as cardiology, obstetrics, and emergency care [1][3]. - The company has received medical device registration for three ultrasound systems: uSONIQUE Pulse, uSONIQUE Genesis, and uSONIQUE Venus, completing its medical imaging product portfolio [3]. - The entry into the ultrasound market comes after the company initially focused on CT and MR products since its establishment in 2011, with ultrasound research starting in 2019 [3][4]. Group 2: Market Dynamics and Competition - The ultrasound market in China is valued at over 10 billion, with significant global business potential, indicating a competitive landscape where all manufacturers are on a level playing field due to advancements in AI [4]. - Major competitors in the domestic ultrasound market include Mindray and foreign firms like GE and Philips, with a trend towards high-end products as low-end ultrasound devices contribute minimally to profits [8][9]. - Mindray reported that high-end and ultra-high-end models accounted for 63% of its domestic ultrasound revenue, highlighting the shift towards premium products in the market [8]. Group 3: Sales Strategy and Future Outlook - The company aims to leverage its established distribution channels and trust relationships with hospitals to facilitate the sales of its new ultrasound products [9]. - A physician noted that imaging is interconnected, suggesting that United Imaging Healthcare's comprehensive product line could provide hospitals with integrated solutions [9]. - For the first three quarters of 2025, the company reported revenues of 8.859 billion and a net profit of 1.120 billion, with significant growth in overseas markets contributing to overall performance [11].

新华财经上海11月14日电（记者杨有宗）联影医疗近日正式发布超声uSONIQUE系列产品。这也是联影 继在PET/CT、CT、MR、XR等领域后，其在医学影像领域的进一步拓展。 据介绍，此次新品包括了从超高端到高端、中端再到经济型全系列超声产品矩阵，涵盖台式、便携、掌 上等多种形态产品，全面支持临床超声中包括全身、心脏、心内科、产科、妇科，儿科，生殖、血管、 重症监控、急救、麻醉、床旁等在内的多个科室和应用场景。 联影医疗超声事业部总裁林峰介绍："新的技术浪潮下，联影希望充分发挥后来者优势，以及多年来在 医学影像领域积累的专业洞察与能力，以AI来重新定义超声，推动超声诊疗从 '依赖人工' 向 '智能自 主'、从 '个体经验' 向 '标准均质'、从 '特定场景' 向 '全域覆盖' 的范式跃迁，推动诊疗效率与精准度的 大幅提升。" （文章来源：新华财经） "超声是联影必须布局的关键领域。不仅是我们践行'健康大同'愿景的重要抓手，也是联影诊疗融合生 态布局中不可或缺的一环。特别在当下，以人工智能为主的新一轮科技革命驱动下，超声正处在前所未 有的技术变革窗口期，有机会实现颠覆性的创新突破。"联影集团董事长薛敏表示。 ...

【环球网科技综合报道】2025年11月12日，国产高端医疗影像龙头联影医疗正式发布超声uSONIQUE系列产品。这也是联影继在PET/CT、CT、MR、XR等 领域改变行业格局后，补齐其在医学影像领域的最后一块拼图。 联影医疗超声事业部总裁林峰介绍称，"新的技术浪潮下，联影希望充分发挥后来者优势，以及多年来在医学影像领域积累的专业洞察与能力，以AI来重新 定义超声，推动超声诊疗从 '依赖人工' 向 '智能自主'、从 '个体经验' 向 '标准均质'、从 '特定场景' 向 '全域覆盖' 的范式跃迁，推动诊疗效率与精准度的大 幅提升。" 例如，AIStream全流程智能工作流，业界首次实现了超声诊断从超声探头激活、不同切面扫描存储、数据分析到最终输出报告全流程的智能化，让超声变得 更"聪明"：从医生拿起探头准备扫查时，配备了位置传感器的探头检测到运动姿态就会自动激活；扫查过程中，设备可以自主识别扫描的切面，并进行质量 评价；随后自动存储符合质量要求的切面、自动测量和注释，最后自动生成完整报告。不仅从源头保障图像质量的标准化和高端化，而且降低了操作门槛， 医生无需手动操作按钮，只需要拿起探头扫查就可以完成整个检查任务 ...

南方财经11月12日电，记者获悉，联影医疗今日正式发布超声uSONIQUE系列产品。据介绍，此次新品 包括了从超高端到高端、中端再到经济型全系列超声产品矩阵，涵盖台式、便携、掌上等多种形态产 品，全面支持临床超声中包括全身、心脏、心内科、产科、妇科，儿科，生殖、血管、重症监控、急 救、麻醉、床旁等在内的多个科室和应用场景。这也是联影继在PET/CT、CT、MR、XR等领域改变行 业格局后，补齐其在医学影像领域的最后一块拼图。（21世纪经济报道） ...